Bifidobacterium animalis subsp. lactis F1-7 Probiotics Powder from China Suppliers and Factory for Gut Health
Deposite: CCTCC M 2020833
Shelf life: 24 months
Storage conditions: Stored at -18℃or lower
Health Benefits
Patents
ZL202110565814.X
A strain of Bifidobacterium animalis subsp.lactis F1-7 that promotes intestinal motility and its applications.
ZL202110019976.3
Patent Title: A method of preparing a combination of Bifidobacterium animalis subsp.lactis F1-7 and krill oil for ameliorating atherosclerotic inflammation and its application
Literature
1. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis
2. Study on intestinal survival and cholesterol metabolism of probiotics
3. Evaluation of probiotics for improving and regulation metabolism relevant to type 2 diabetes in vitro
4. Study of gastrointestinal tract viability and motility via modulation of serotonin in a zebrafish model by probiotics
5. Bifidobacterium animalis F1-7 in combination with konjac glucomannan improves constipation in mice via humoral transport
6. Bifidobacterium improves oestrogen-deficiencyinduced osteoporosis in mice by modulating intestinal immunity
7. Krill Oil Combined with Bifidobacterium animalis subsp. lactis F1-7 Alleviates the Atherosclerosis of ApoE Mice
8. Mechanisms underlying the promotion of 5- hydroxytryptamine secretion in enterochromaffin cells of constipation mice by Bifidobacterium and Lactobacillus
9. Probiotics improved hyperlipidemia in mice induced by a high cholesterol diet via downregulating FXR
10. Ameliorative Effect and Mechanism of Probiotics Combined with Resveratrol on Chronic Alcoholic Liver Injury in Mice
Applications
Dairy
Food
Fermented Beverages
Pharmaceuticals
Biotechnology
Feed Additive/Pet
Products List
Products customized are acceptable.
Potency options: 10B CFU/g, 50B CFU/g, 100B CFU/g, 200B CFU/g, 300B CFU/g, 400B CFU/g, 500B CFU/g
| Probiotic Strains | Strain number | Potency (BCFU/g) |
|---|---|---|
| Bifidobacterium animalis subsp.lactis | F1-7 | 200 |
| Bifidobacterium animalis subsp.lactis | KV9 | 800 |
| Bifidobacterium animalis subsp.lactis | BA-C9 | 200 |
| Bifidobacterium animalis subsp.lactis | BA-C10 | 800 |
| Bifidobacterium animalis subsp.lactis | BA-C53 | 600 |
| Lactiplantibacillus plantarum | F3-2 | 800 |
| Lactiplantibacillus plantarum | YZX21 | 500 |
| Lactiplantibacillus plantarum | H-87 | 600 |
| Lactiplantibacillus plantarum | LP-C2 | 800 |
| Lactiplantibacillus plantarum | LP-C3 | 500 |
| Lactiplantibacillus plantarum | LP-C1 | 600 |
| Lactiplantibacillus plantarum | LP-C5 | 300 |
| Lactiplantibacillus plantarum | LP-C77 | 800 |
| Lacticaseibacillus paracasei | G15 | 500 |
| Lacticaseibacillus paracasei | J5 | 800 |
| Lacticaseibacillus paracasei | X11 | 800 |
| Lacticaseibacillus paracasei | LPC-C8 | 500 |
| Lacticaseibacillus paracasei | LPC-C7 | 800 |
| Lacticaseibacillus paracasei | Lpc-C66 | 800 |
| Lacticaseibacillus paracasei | LPC-C6 | 500 |
| Lacticaseibacillus casei | YRL577 | 500 |
| Lacticaseibacillus casei | LC-C64 | 500 |
| Lactobacillus acidophilus | LA-C29 | 300 |
| Lacticaseibacillus rhamnosus | LR-GG | 300 |
| Lacticaseibacillus rhamnosus | LR-C55 | 500 |
| Lacticaseibacillus rhamnosus | LR-C19 | 300 |
| Bifidobacterium longum subsp. longum | BL-C54 | 200 |
| Bifidobacterium longum subsp. longum | BL-C62 | 200 |
| Bifidobacterium longum subsp. infantis | BI-C71 | 100 |
| Bifidobacterium breve | BB-C51 | 300 |
| Limosilactobacillus fermentum | LF-C57 | 500 |
| Streptococcus salivarius subsp.thermophilus | ST-C13 | 200 |
| Pediococcus acidilactici | PA-C81 | 800 |
| Pediococcus pentosaceus | PP-C80 | 800 |
Frequently Asked Questions
Q: What are the primary health benefits of Bifidobacterium animalis subsp. lactis F1-7?
A: Based on our patented research, Bifidobacterium animalis subsp. lactis F1-7 is specifically developed to promote intestinal motility, alleviate constipation, and, when combined with krill oil, assist in ameliorating atherosclerotic inflammation.
Q: Can I request custom probiotic formulations or potencies?
A: Yes, customized products are acceptable. We can adjust the strains and configure the potency options ranging from 10B CFU/g up to 500B CFU/g to meet your specific formulation requirements.
Q: In which industries can these probiotic strains be applied?
A: Our premium probiotic strains are highly versatile and suitable for applications in Dairy, Food, Fermented Beverages, Pharmaceuticals, Biotechnology, and Feed Additives/Pet food products.
Q: Is there scientific validation backing these probiotic strains?
A: Yes. Multiple literature studies support our strains, documenting their efficacy in lipid metabolic disorders, gastrointestinal viability, estrogen-deficiency induced osteoporosis modulation, and protection against chronic alcoholic liver injuries.
Q: How do these probiotics survive the gastrointestinal tract?
A: Our strains, including Bifidobacterium animalis F1-7, have been evaluated for high gastrointestinal tract viability and survival rates, ensuring they remain active to modulate serotonin levels and support gut health.